

$ELVN has been discussed by two FinTwit voices across 20 mentions over a 12-month period from December 2025 through June 2026. Jacob Plieth (@jacobplieth) accounts for 18 of these mentions, while Adam Feuerstein (@adamfeuerstein) contributed 2 mentions. The biotech category dominates discussion of Enliven Therapeutics, with focus concentrated around clinical trial data and development updates.
@jacobplieth (Jacob Plieth) mentions $ELVN most — 18 mentions in the past 12 months.
The earliest tracked mention of $ELVN in the Surfaced archive was on Dec 9, 2025.
2 FinTwit voices have mentioned $ELVN 20 times in the past 12 months.
$ELVN is mentioned most by Biotech voices on Surfaced.
